Drug Repurposing Firm Every Cure Bags $60m Investment
The Biotech’s Own President Is ‘Alive’ Because Of Repurposing A Transplant Drug
Backed by AI and former FDA official Janet Woodcock, Every Cure is set to identify approved drugs for patients who don’t have treatment options around the world.
